Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
On Nov. 3, 2025, Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about…
In 1959, Johnson ᅠ&ᅠ Johnson acquired McNeil Laboratories giving the Company a significant presence in the growing field…